Journal of SAFOMS

Register      Login

VOLUME 1 , ISSUE 2 ( July-December, 2013 ) > List of Articles

REVIEW ARTICLE

Menopause and Gynecological Malignancy

Sabera Khatun

Citation Information : Khatun S. Menopause and Gynecological Malignancy. J South Asian Feder Menopause Soc 2013; 1 (2):75-79.

DOI: 10.5005/jp-journals-10032-1017

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Available from: http://www.managingmenopause.org.au/health-issues.
  2. Persistent HPV infection in postmenopausal age women. Int J Gynaecol Obstet 2004;87(2):131-137.
  3. Incidence of cervical cytological abnormalities with aging in the women's health initiative. Obstet Gynecol 2006;108(2):410-419.
  4. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006;66(2):1218-1224.
  5. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191(11):1808-1816 view at Publisher, view at google scholar, view at PubMed, View at scopus.
  6. Cervical cancer screening practices among older women: results from the Maryland cervical cancer case-control study. J Clin Epidemiol 1988;41(6):531-541 view at scopus.
  7. Decreased incidence of cervical cancer in medicareeligible California women. Obstet Gynecol 2002;100(1):79-86.
  8. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) phase II trial. Gynecol Oncol 2008;109:329-334.
  9. A randomized trial of adriamycin versus no adjuvant chemotherapy in stage I and II uterine sarcomas. J Clin Oncol 1985;9:1240-1245.
  10. Mesenchymal and mixed epithelialmesenchymal tumors of the uterine corpus and cervix. In: Clement PB, Young RH, editors. Atlas of gynecologic surgical pathology. Philadelphia: WB Saunders; 2000. p. 177-210.
  11. Available at: http://globocan.iarc.fr . Accessed July 2012.
  12. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. In: Atlas of tumor pathology. 3rd series, fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998. p. 1-168.
  13. Ovarian Cancer National Alliance. Available from: http://www.ovariancancer.org/about-ovarian-cancer/statistics.
  14. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA 1 and BRCA 2. Science 2003;302:643-646.
  15. Reuters; 2013 January 30.
  16. Women's health source: ovarian cysts and masses in menopause. Available at: http://www.mainlinehealth.org/oth/Page.asp?PageID=OTH004241.
  17. A risk of malignancy index incorporating CA-125, ultrasound and menopausal status in the preoperative diagnosis of ovarian cancer. Brit J Obstet Gynecol 1990;97:922-929.
  18. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 versus CP) in advanced ovarian carcinoma: a randomized trial of the Netherlands joint study group for ovarian cancer. J Clin Oncol 1987;5:1157-1168.
  19. Endometrial cancer. Available at: http://www3.cancer.gov/admin/fmb/2001sigitems/endometrial.html. Accessed on: August 26, 2002.
  20. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1-16.
  21. Endometrial carcinoma: pathology and genetics. Pathology 2007;39:1-7.
  22. Carcinoma of the corpus uteri. FIGO Annual Report, Vol 26. Int J Gynaecol Obster 2006;95(suppl 1):S105-S143.
  23. Screening for endometrial cancer. Med J Aust 2003;178(12):657-659.
  24. Routine cancer screening. Committee Opinion #247. Washington, DC: ACOG; Dec 2000.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.